 
 
Statistics Guide for Research Grant Applicants
Checklist
This checklist can be downloaded as an Adobe Acrobat PDF
file, for ease of printing.
Tick [ ] those that apply
Design
  -  Is the study observational? [   ]
 (see A-1.1 and A-1.2)
-  If Yes
    
      -  Is it a cohort study? [   ]
 (see A-1.3)
-  Is it a case-control study? [   ]
 (see A-1.4)
-  Is it a cross-sectional study? [   ]
           (see A-1.5)
      
-  If Yes to cross-sectional study
           
             -  Is it a prevalence study? [   ]
 (see A-1.5a)
-  Is it estimating sensitivity and specificity? [ 
 ]
 (see A-1.5b and A-1.5c)
-  Is it an ecological study? [   ]
 (see A-1.5d)
 
-  Have you addressed the issue of confounding in your proposal?
           [   ]
 (see A-1.6)
 
-  Is the study experimental? [   ]
 (see A-1.1, A-1.2)
-  If Yes
    
      -  Is the study a type of trial e.g. a clinical trial? [ 
 ]
 (see A-1.7, A-1.8)
-  If Yes
        
          -  Is the study a controlled  trial (i.e. is there a
               control group)? [   ]
 (see A-1.8 and B-3)
-  Is it a randomised trial
               (i.e. are study subjects randomly allocated to groups)? [ 
 ]
 (see A-1.8 and B-5)
-  If Yes to randomised trial
            
              -  Is it important to have similar numbers in each
                   randomisation group? (you may need to use blocks) [ 
 ] 
 (see B-5.6)
-  Are any known factors strongly prognostic? [ 
 ]
 (you may need to randomise in strata)
 (see B-5.7)
-  If Yes to strongly prognostic factors
                
                  -  Is the proposed sample size small? [   ]
 (see B-5.8)
 
-  Are groups of individuals to be randomised together
                   to the same treatment? [   ]
 (see B-5.9)
-  Is this a cross over trial? [   ]
 (see B-5.10b)
-  Is the assessor blind? [   ]
 (see A-1.8 and B-4)
-   Are the study subjects blind? [   ]
 (see A-1.8 and B-4)
 
 
 
-  Is the study prospective? [   ]
 (see A-2)
-  If Yes
    
      -  Have you specified the length of follow up? [   ]
 (see A-2)
 
The Study Subjects
(see A-3)
  -  Have you described where they come from? [   ]
  
-  Have you explained why they are an appropriate group? [   ]
  
-  Have you described how the study subjects will be selected? [ 
 ]
  
-  Have you specified inclusion / exclusion criteria? [   ]
  
-  Have you specified your proposed sample size taking into account
refusals/drop-outs? [   ]
Types of Variables
(see A-4)
  -  Have you described all outcome and explanatory variables in
       terms of data type and scale of measurement? [   ]
 (see A-4.1 and A-4.2)
-  Have you described how the data will be collected? [   ]
 (see A-4.3)
-  If using a questionnaire or a non-standard measurement, have
       you provided information on its reliability and validity? [ 
 ]
 (see A-4.4, A-4.4a, A-4.4b, A-4.4c)
Sample Size
  -  Have you provided a sample size calculation? [   ] 
 (see D-1)
-  Have you defined the outcome variable(s) used in the sample
       size calculation? [   ]
 (see D-5)
-  Have you defined the effect size which would be of clinical
       importance? [   ] 
 (see D-4.5)
-  Have you described the power and significance level of the sample
       size calculation? [   ]
 (see D-4.3 and D-4.4)
-  Has your sample size made allowance for expected response rates
       and other sample attrition? [   ] 
 (see D-6)
-  Is your sample size consistent with the study aims? [   ] 
 (see D-7)
-  Is your sample size consistent with the proposed analysis of the
       study? [   ] 
 (see D-7)
-  Is your description of the sample size calculation adequate? [ 
 ] 
 (See examples in D-8)
Statistical Analysis
  -  Have you described the proposed statistical methods using
       appropriate terminology? [   ]
 (see E-1.1, E-1.2)
-  Are the proposed methods appropriate for the types of data generated
       by your study? [   ]
 (see E-2, E-2.1, E-11)
-  Will the assumptions made by the proposed methods hold? [ 
 ]
 (see E-4, E-4.1)
-  Do the proposed methods take account of the structure of the data
       set (structure such as hierarchy, clustering, matching, paired
       data)? [   ]
 (see E-3, E-6, E-6.2, E-10)
-  Have important confounding factors been listed and methods of
       adjusting for them presented?  [   ]
 (see E-5)
-  Will the proposed methods take account of multiple testing
       where appropriate? [   ]
 (see E-7.1, E-7.2, E-7.3, E-7.4, E-7.4a, E-7.4b, E-7.4c,
E-7.4d, E-7.4e, E-7.4f)
-  Have biases due to measurement error been considered e.g.
       regression towards the mean? [   ]
 (see E-8)
-  Have details on the calculation of confidence intervals been
       provided? [   ]
 (see E-12)
For clinical trials only
  -  Have you specified that your analysis will be by intention to
       treat? [   ]
 (see E-9)
Back to Brief Table of Contents.
 
Back to Martin Bland's home page.
This page is maintained by Martin Bland.
Last updated: 10 September, 2009.
 Back to top